Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Mast Therapeutics Company Profile (NASDAQ:MSTX)

Consensus Ratings for Mast Therapeutics (NASDAQ:MSTX) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $2.23 (375.18% upside)

Analysts' Ratings History for Mast Therapeutics (NASDAQ:MSTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/17/2014Canaccord GenuityInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2014Piper JaffrayReiterated RatingOverweight$1.00 -> $1.20ViewTweet This Rating  Share This Rating on StockTwits
9/8/2014LaidlawReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
8/6/2014LaidlawInitiated CoverageBuy$2.50ViewTweet This Rating  Share This Rating on StockTwits
6/16/2014Evercore ISIInitiated CoverageReduceViewTweet This Rating  Share This Rating on StockTwits
10/3/2013Canaccord GenuityInitiated CoverageReduce -> Buy$3.00ViewTweet This Rating  Share This Rating on StockTwits
10/3/2013Cantor FitzgeraldInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Piper JaffrayInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
4/2/2013JMP SecuritiesInitiated CoverageOutperform$2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 1/25/2013 forward)